Xaira Therapeutics
Biotech · San Francisco, US
AI-driven drug discovery using protein-design models.
Funding history
| Date | Round | Amount |
|---|
| Apr 2024 | Funding round Xaira Therapeutics launched with over $1B co-led by Arch Venture Partners and Foresite Labs for AI drug discovery. | $1B |
Investors
ARCH Venture PartnersForesite LabsLux CapitalNEASequoia Capital
Similar companies in Biotech
Explore funding flow on EquityFlow →